Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody
David Falck(Leiden University Medical Center), Dietmar Reusch(Roche Pharma AG (Germany)), Cordula Jany(Roche Pharma AG (Germany)), Martin Lechmann(Roche (Switzerland)), Manfred Wuhrer(Leiden University Medical Center), Carolien A. M. Koeleman(Leiden University Medical Center), Sebastian Malik(Roche Pharma AG (Germany)), Marco Thomann(Roche Pharma AG (Germany))
Cited by 42
Related Papers
High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations
|Molecular & Cellular Proteomics|2011|533
Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity
|Science|2020|415
Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers
|PLoS Genetics|2013|376
Integrative epigenome-wide analysis demonstrates that DNA methylation may mediate genetic risk in inflammatory bowel disease
|Nature Communications|2016|273